First-Ever Domestic HCD Detection Kits Developed

A domestic knowledge-based company has produced host cell DNA (HCD) detection kits used to develop different kinds of medicines for the first time in Iran.
All biological medicines are produced in a living cell, and one of the requirements of regulatory organizations for biological medicine is that there should be nothing from the medicine-producing cell, either protein or DNA of the host cell, in the purified medicine, the news portal of Vice Presidency for Science and Technology reported.
Currently, Livogen Pharmed Company produces five dedicated HCD kits for host cell DNA detection for CHO, BHK, SP2/0, E. coli and yeast cell lines, which are the main medicine-producing hosts in the biotechnology industry.
These kits have been optimized based on the sensitive real-time PCR technique and are capable of quantitatively measuring the remaining DNA of the host cell in the medicine.